PIONEER 6

Definition

The cardiovascular safety trial of oral semaglutide (Rybelsus) in adults with type 2 diabetes at high cardiovascular risk. Husain and colleagues (NEJM 2019) demonstrated noninferiority for MACE — establishing that oral GLP-1 administration delivers the same cardiovascular safety signal as the subcutaneous formulation.

PIONEER 6 trial deep-dive →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in trial

• SURMOUNT-5
• SURMOUNT-2
• SURMOUNT-3
• SURPASS-2
• SUSTAIN-6
• REWIND
• STEP-HFpEF
• EXSCEL
• ELIXA
• AMPLITUDE-O
• HARMONY OUTCOMES
• SCALE Diabetes
• STEP 2
• SUMMIT
• SCALE Maintenance

Looking for more depth?

• PIONEER 6 trial deep-dive
• Browse the full GLP-1 glossary (124 terms across 8 categories)
• Research articles — primary-source deep dives
• Tools and calculators
• Compare GLP-1 telehealth providers